BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16520989)

  • 1. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
    Yang B; Fan L; Fang L; He Q
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC; Pérez-Yarza G; Nieto-Rementeria N; Boyano MD; Jangi M; Atencia R; Asumendi A
    Anticancer Res; 2005; 25(3B):1945-51. PubMed ID: 16158929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
    Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
    Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
    Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells.
    Yang X; Hao Y; Ding Z; Pater A
    Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2.
    Morales MC; Pérez-Yarza G; Rementería NN; Boyano MD; Apraiz A; Gómez-Muñoz A; Pérez-Andrés E; Asumendi A
    Free Radic Res; 2007 May; 41(5):591-601. PubMed ID: 17454142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
    Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
    Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D; Gopal AK; Press OW
    Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
    Yang B; Reynolds CP
    Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.
    Darwiche N; Hatoum A; Dbaibo G; Kadara H; Nasr R; Abou-Lteif G; Bazzi R; Hermine O; de Thé H; Bazarbachi A
    Leukemia; 2004 Mar; 18(3):607-15. PubMed ID: 14712289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
    O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ
    Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
    Holmes WF; Soprano DR; Soprano KJ
    J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of fenretinide-triggered apoptosis in leukemic cells].
    Xiao DK; Du YZ; Fan HY; Chen YL; Chen Z; Zhang J; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):975-8. PubMed ID: 16403262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.
    Kouhara J; Yoshida T; Nakata S; Horinaka M; Wakada M; Ueda Y; Yamagishi H; Sakai T
    Int J Oncol; 2007 Mar; 30(3):679-87. PubMed ID: 17273769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.
    Anding AL; Chapman JS; Barnett DW; Curley RW; Clagett-Dame M
    Cancer Res; 2007 Jul; 67(13):6270-7. PubMed ID: 17616685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.